Skip to main content

Advertisement

Log in

Long-Term Outcome of Transcatheter Subsegmental and Segmental Arterial Chemoemobolization Using Lipiodol for Hepatocellular Carcinoma

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To clarify the efficacy of transcatheter hepatic sub-subsegmental, subsegmental, and segmental arterial chemoembolization using lipiodol (subseg/seg lip-TACE) for hepatocellular carcinoma (HCC), long-term outcomes of patients who had been treated using subseg/seg lip-TACE alone were retrospectively examined.

Materials and Methods

Subjects comprised 199 patients with HCC (T1/2/≥3 = 30/108/61; Child–Pugh A/B/C = 115/52/32; Japan Integrated Staging [JIS] score ≤1/2/≥3 = 88/64/47) who underwent subseg/seg lip-TACE using lipiodol mixed with an anticancer drug followed by injection of gelatin sponge particles. Each patient was followed-up every 3 months, and repeat subseg/seg lip-TACE and/or conventional lip-TACE was performed in cases showing recurrence. One-, 3-, 5-, 7-, and 10-year cumulative survival rates were calculated. Subgroup analyses were performed by stratifying the population according to T-factor, Child–Pugh classification, and JIS score.

Results

Median duration of follow-up was 3.8 years (range 0.2 to 16.4). Median overall survival was 3.8 years. One-, 3-, 5-, 7- and 10-year survival rates were 91.5, 66.1, 38.8, 20.3, and 9.4% for all patients, and 95.5, 76.9, 51.9, 27.9 and 20.4% for patients with JIS ≤1, respectively. Significant survival differences were found across two subgroups of staging systems (T2 vs. T3≤ [P = 0.0012] and JIS score ≤1 vs. 2 [P = 0.0036]).

Conclusion

This study demonstrated that subseg/seg lip-TACE is a feasible treatment for obtaining prolonged survival in patients with localized HCC showing rich vasculature. Outcomes are influenced by both tumor stage and liver function, as seen in the best prolonged survival in patients with JIS score ≤1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ohishi H, Uchida H, Yoshimura H et al (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154:15–19

    Google Scholar 

  2. Ohishi H, Yoshimura H, Uchida H et al (1989) Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug the treatment for hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):S33–S36

    Article  PubMed  Google Scholar 

  3. Nakamura H, Hashimoto T, Oi H et al (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783–786

    PubMed  CAS  Google Scholar 

  4. Uchida H, Ohishi H, Matsuo N et al (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particle for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140–145

    Article  PubMed  CAS  Google Scholar 

  5. Nakamura H, Hashimoto T, Oi H et al (1990) Treatment of hepatocellular carcinoma by segmental hepatic artery injection of adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol 31:347–349

    PubMed  CAS  Google Scholar 

  6. Nakao N, Uchida H, Kamino K et al (1992) Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S72–S76

    Article  PubMed  Google Scholar 

  7. Uchida H, Matsuo N, Sakaguchi H et al (1993) Segmental embolotherapy for hepatic cancer: Key to success. Cardiovasc Intervent Radiol 16:67–71

    Article  PubMed  CAS  Google Scholar 

  8. Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol. Hepatic arterial and segmental use. Semin Intervent Radiol 10:19–26

    Article  Google Scholar 

  9. Matsuo N, Uchida H, Nishimine K et al (1993) Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vasc Interv Radiol 4:543–549

    Article  PubMed  CAS  Google Scholar 

  10. Matsui O, Kadoya M, Yoshikawa J, Gabata T et al (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83

    PubMed  CAS  Google Scholar 

  11. Nishimine K, Uchida H, Matsuo N et al (1994) Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33(Suppl):S60–S68

    Article  PubMed  Google Scholar 

  12. Nakao N, Uchida H, Kamino K et al (1994) Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol 17:76–80

    Article  PubMed  CAS  Google Scholar 

  13. Matsuo N, Uchida H, Sakaguchi H et al (1997) Optimal lipiodol volume in transcatheter arterial chemoembolization for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 24(Suppl 6):61–70

    Google Scholar 

  14. Nakamura H, Hashimoto T, Oi H, Sawada S (1998) Iodized oil in the portal vein after arterial embolization. Radiology 167:415–417

    Google Scholar 

  15. Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176:681–688

    PubMed  CAS  Google Scholar 

  16. Itsubo M, Koike K, Tsuno S et al (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenteroly 49:735–739

    Google Scholar 

  17. Higashihara H, Okazaki M (2002) Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenteroly 49:72–78

    Google Scholar 

  18. Iwamoto S, Sanefuji H, Okuda K (2003) Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer 97:1051–1056

    Article  PubMed  Google Scholar 

  19. Miyayama S, Matsui O, Yamashiro M et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein iodized oil. J Vasc Interv Radiol 29:39–48

    Google Scholar 

  20. Iwamoto S, Yamaguchi T, Hongo O et al (2010) Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma. Cancer 15:393–399

    Article  Google Scholar 

  21. Miyagawa S, Kawasaki S (1998) Subsegmentectomy or segmentectomy in hepatocellular carcinoma. Hepatogastroenteroly 45:2–6

    CAS  Google Scholar 

  22. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209

    Article  PubMed  Google Scholar 

  23. Hasegawa K, Makuuchi M, Takayama T et al (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49:589–594

    Article  PubMed  Google Scholar 

  24. Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260–266

    Article  PubMed  Google Scholar 

  25. Miyayama S, Matsui O, Taki K et al (2006) Extrahepatic blood supply to hepatocellular carcinomas: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 29:39–48

    Article  PubMed  Google Scholar 

  26. Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192:1057–1063

    Article  PubMed  Google Scholar 

  27. Miyayama S, Yamashiro M, Yoshie Y et al (2010) Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography. Jpn J Radiol 28:555–562

    Article  PubMed  Google Scholar 

  28. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469

    Article  PubMed  CAS  Google Scholar 

  29. Takayasu K, Arii S, Ikai I et al (2010) Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma. Propensity score analysis. AJR Am J Roentgenol 194:830–837

    Article  PubMed  Google Scholar 

  30. Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 31:756–761

    Article  PubMed  Google Scholar 

  31. Liver Cancer Study Group of Japan (2008) The general rules for the clinical and pathological study of primary liver cancer (in Japanese), 5th edn. Kanehara, Tokyo, p 24

    Google Scholar 

  32. Kudo M, Chungg H, Haji S et al (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score as compared with CLIP score. Hepatology 40:1396–1405

    Article  PubMed  Google Scholar 

  33. Okusaka T, Okada S, Nakanishi T et al (2004) Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 22:169–176

    Article  PubMed  CAS  Google Scholar 

  34. Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 31:1108–1116

    Article  PubMed  Google Scholar 

  35. Pelletier G, Roche A, Ink O et al (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181–184

    Article  PubMed  CAS  Google Scholar 

  36. Madden MV, Krige JE, Bailey S et al (1993) Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34:1598–1600

    Article  PubMed  CAS  Google Scholar 

  37. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  38. Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583

    Article  PubMed  CAS  Google Scholar 

  39. Pelletier G, Ducreux M, Gay F et al (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicentre randomized trial. Groupe CHC. J Hepatol 29:129–134

    Article  PubMed  CAS  Google Scholar 

  40. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  PubMed  CAS  Google Scholar 

  41. Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734–1739

    Article  PubMed  Google Scholar 

  42. Ernst O, Sergent G, Mizrahi D et al (1999) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172:59–64

    PubMed  CAS  Google Scholar 

  43. Shim JH, Park JW, Choi JI et al (2009) Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 20:209–216

    Article  PubMed  Google Scholar 

  44. Sakaguchi H, Uchida H, Maeda M et al (1995) Combined transjugular intrahepatic portosystemic shunt and segmental lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. Cardiovasc Intervent Radiol 18(1):9–15

    Article  PubMed  CAS  Google Scholar 

  45. Miyayama S, Yamashiro M, Okuda M et al (2010) Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:1168–1179

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Anai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takaki, S., Sakaguchi, H., Anai, H. et al. Long-Term Outcome of Transcatheter Subsegmental and Segmental Arterial Chemoemobolization Using Lipiodol for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 35, 544–554 (2012). https://doi.org/10.1007/s00270-011-0224-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0224-9

Keywords

Navigation